Professor Masquelier and French Pine Bark
More than 50 years ago, Professor Jack Masquelier was famously the first to discover OPCs and later how to produce extracts from vitis vinifera seeds and French Pine Bark to release their potent health benefits. These precise extracts have been manufactured in France since 1968 (under steady control by the French Ministry of Health). Today, these same potent extract are produced by the International Nutrition Company (INC) as “MASQUELIER’s®” in the same original and authentic form, renowned for their remarkable health benefits.
What OPCs are
OPCs provide a unique combination of condensed forms of the vegetal molecule known as flavan-3-ol found and concentrated in the woody parts of plants. Renowned for their phenomenol support of human health, this substance is not naturally produced by the body and cannot be synthetically reproduced. Professor Masquelier discovered OPC’s and harnessed their power to create OPC based medicines.
Professor Masquelier and Mediterranean health
Recognising the health benefits of Mediterranean lifestyle, Professor Masquelier also researched major ingredients of the traditional Mediterranean diet and their associated health benefits. Masqueliers’ knowledge in isolating and researching essential compounds from Mediterranean foods, greatly contributed to understanding their health benefits.
The legacy of Professor Masqulier – MASQUELIER’s®
As OPCs became commercially produced, Professor Masquelier experienced disappointment at witnessing his groundbreaking discoveries become watered-down versions of his original research and vision. By partnering with INC to create MASQUELIER’s® OPC products and providing regular guidance concerning their manufacture over a period of almost 30 years, he was able to ensure that his legacy would continue in its most potent and authentic form.
With Professor Masquelier’s full support and experience, the MASQUELIER’s® brand was born. MASQUELIER’s® is the legacy of Professor Masquelier, after a lifetime of research, discovery, development and dedication. Utilising today’s most advanced analytical methods, INC continues to uphold his rigourous standards of optimum quality and efficacy.
Professor Masquelier’s career, research and development
Born in 1922 in Paris, Dr. Masquelier got his degree in Pharmacy in 1945 and his doctorate in 1948. He has worked at the “Faculty de Medecine et de Pharmacie” of the University of Bordeaux, France, from 1941 until 1984. He was Doctor Honoris Causa of the University of Quebec (1974) and Doctor Honoris Causa of the University of Portugal (1996).
In July 1948, Jack Masquelier published his doctorate thesis on the successful isolation and chemical description of the phytonutrient oligomeric proanthocyanidins or OPCs. That same year he filed a patent for the industrial method of producing the first botanical product based on OPCs.
Based on Dr. Masquelier’s groundbreaking innovations in the research and development of OPCs isolation, identification and therapeutic and dietary application, he deveoped two botanical products. In the 1960s, a botanical medicine based on OPCs isolated from Pinus maritima bark (now known as MASQUELIER’s® French Pine Bark Extract) was developed, followed ten years later by another OPCs-based medicinal product manufactured from Vitis vinifera seeds. In France, these medicinal products are still sold today.
Through tireless scientific investigation, Dr. Masquelier revealed the numerous health benefits of OPCs. The key early finding of Dr. Masquelier was that OPCs strengthen and protect blood vessels and vascular function, essential for the function of every organ in the body. This set in motion a series of independent clinical studies by several other scientists that sustained Dr. Masquelier’s findings and provided conclusive support for the use of Masquelier’s OPCs-compounds in the French vasculo-protective medicines.
In 1985, Dr. Masquelier was able to further explain the intense and instant positive effects that OPCs have on the human body when he discovered that OPCs neutralize free radicals, the common cause of seemingly unrelated degenerative conditions and early onset of age-associated changes in the body. He found that OPCs are powerful antioxidants and are unique in their ability to work in both aqueous and lipid phase to provide superior antioxidant support.
Dr. Jack Masquelier’s discoveries have greatly influenced human health worldwide, and continue to become of greater significance as life expectancy increases with a dramatic increase in cardiovascular and degenerative diseases.